BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30394698)

  • 1. Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.
    Watanabe Y; Tsuchiya A; Seino S; Kawata Y; Kojima Y; Ikarashi S; Starkey Lewis PJ; Lu WY; Kikuta J; Kawai H; Yamagiwa S; Forbes SJ; Ishii M; Terai S
    Stem Cells Transl Med; 2019 Mar; 8(3):271-284. PubMed ID: 30394698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
    Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
    Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.
    Fiore E; Malvicini M; Bayo J; Peixoto E; Atorrasagasti C; Sierra R; Rodríguez M; Gómez Bustillo S; García MG; Aquino JB; Mazzolini G
    Stem Cell Res Ther; 2016 Nov; 7(1):172. PubMed ID: 27876093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions.
    Kojima Y; Tsuchiya A; Ogawa M; Nojiri S; Takeuchi S; Watanabe T; Nakajima K; Hara Y; Yamashita J; Kikuta J; Takamura M; Ishii M; Terai S
    Regen Ther; 2019 Dec; 11():269-281. PubMed ID: 31667206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.
    Fiore EJ; Bayo JM; Garcia MG; Malvicini M; Lloyd R; Piccioni F; Rizzo M; Peixoto E; Sola MB; Atorrasagasti C; Alaniz L; Camilletti MA; Enguita M; Prieto J; Aquino JB; Mazzolini G
    Stem Cells Dev; 2015 Mar; 24(6):791-801. PubMed ID: 25315017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
    Luo XY; Meng XJ; Cao DC; Wang W; Zhou K; Li L; Guo M; Wang P
    Stem Cell Res Ther; 2019 Jan; 10(1):16. PubMed ID: 30635047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
    Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
    Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
    Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.
    Kim MD; Kim SS; Cha HY; Jang SH; Chang DY; Kim W; Suh-Kim H; Lee JH
    Exp Mol Med; 2014 Aug; 46(8):e110. PubMed ID: 25145391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
    Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y
    Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages.
    Cho DI; Kim MR; Jeong HY; Jeong HC; Jeong MH; Yoon SH; Kim YS; Ahn Y
    Exp Mol Med; 2014 Jan; 46(1):e70. PubMed ID: 24406319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC
    Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers.
    van der Helm D; Barnhoorn MC; de Jonge-Muller ESM; Molendijk I; Hawinkels LJAC; Coenraad MJ; van Hoek B; Verspaget HW
    J Cell Mol Med; 2019 Sep; 23(9):6238-6250. PubMed ID: 31245923
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
    World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
    Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
    Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury.
    Li Q; Zhou X; Shi Y; Li J; Zheng L; Cui L; Zhang J; Wang L; Han Z; Han Y; Fan D
    PLoS One; 2013; 8(4):e62363. PubMed ID: 23638052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.
    Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S
    J Transl Med; 2013 Mar; 11():78. PubMed ID: 23531302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl
    Baig MT; Ghufran H; Mehmood A; Azam M; Humayun S; Riazuddin S
    Biochem Pharmacol; 2021 Apr; 186():114480. PubMed ID: 33617844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis.
    Jang YO; Kim SH; Cho MY; Kim KS; Park KS; Cha SK; Kim MY; Chang SJ; Baik SK
    Biochem Biophys Res Commun; 2018 Feb; 497(1):264-271. PubMed ID: 29428718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model.
    Piryaei A; Valojerdi MR; Shahsavani M; Baharvand H
    Stem Cell Rev Rep; 2011 Mar; 7(1):103-18. PubMed ID: 20182823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.